FOSAPREPITANT

FOSAPREPITANT was reported 13816 times

FOSAPREPITANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 66 0.2882
1 AUTOIMMUNE PERICARDITIS 5 0.2381
2 SWOLLEN JOINT COUNT 47 0.1880
3 ACQUIRED ANTITHROMBIN III DEFICIENCY 2 0.1429
4 LATEROPULSION 1 0.0833
5 EXTRA-AXIAL HAEMORRHAGE 1 0.0588
6 BILIARY ABSCESS 2 0.0571
7 BENIGN NEOPLASM OF EYELID 1 0.0556
8 MEDIASTINAL CYST 1 0.0556
9 LUPUS VULGARIS 69 0.0548
10 IMMUNOTOXICITY 5 0.0439
11 COLD DYSAESTHESIA 1 0.0435
12 ACQUIRED PORPHYRIA 3 0.0423
13 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 87 0.0419
14 CULTURE NEGATIVE 1 0.0417
15 DEEP VEIN THROMBOSIS POSTOPERATIVE 81 0.0404
16 PORPHYRIA ACUTE 57 0.0397
17 X-RAY ABNORMAL 68 0.0380
18 DISLOCATION OF VERTEBRA 85 0.0372
19 ANAL PARAESTHESIA 1 0.0345
20 RETINITIS 59 0.0341
21 DUODENAL ULCER PERFORATION 217 0.0292
22 CSF RED BLOOD CELL COUNT POSITIVE 1 0.0286
23 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 200 0.0279
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 176 0.0271
25 FACET JOINT SYNDROME 86 0.0264
26 AUTOIMMUNE LUNG DISEASE 3 0.0254
27 PRE-ENGRAFTMENT IMMUNE REACTION 2 0.0250
28 BONE EROSION 85 0.0240
29 SWOLLEN JOINT COUNT INCREASED 72 0.0226
30 MUSCLE INJURY 185 0.0223
31 CENTRAL-ALVEOLAR HYPOVENTILATION 1 0.0222
32 HELICOBACTER INFECTION 219 0.0213
33 ANTIPHOSPHOLIPID ANTIBODIES 4 0.0204
34 FOLLICULITIS 211 0.0201
35 BIOPSY MUSCLE ABNORMAL 1 0.0179
36 RHEUMATIC FEVER 75 0.0168
37 PERIPHERAL VENOUS DISEASE 68 0.0166
38 MYIASIS 1 0.0161
39 MATERNAL EXPOSURE TIMING UNSPECIFIED 60 0.0160
40 HAND DEFORMITY 203 0.0155
41 C-REACTIVE PROTEIN 14 0.0151
42 PEMPHIGUS 188 0.0150
43 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 8 0.0143
44 BREAST CANCER STAGE III 91 0.0140
45 C-REACTIVE PROTEIN ABNORMAL 87 0.0135
46 HAMARTOMA 1 0.0132
47 RHEUMATOID FACTOR POSITIVE 73 0.0126
48 GASTROENTERITIS ASTROVIRAL 1 0.0125
49 MALIGNANT NEOPLASM OF EYELID 1 0.0123
50 SOMATIC DELUSION 3 0.0122
51 CYTOTOXIC CARDIOMYOPATHY 1 0.0122
52 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 8 0.0120
53 AUTOIMMUNE DISORDER 113 0.0116
54 PERICARDITIS 193 0.0115
55 DRUG TOLERANCE DECREASED 32 0.0114
56 XERODERMA 3 0.0112
57 HYDROSALPINX 1 0.0109
58 BLOOD ANTIDIURETIC HORMONE INCREASED 1 0.0108
59 LATERAL MEDULLARY SYNDROME 1 0.0104
60 SYNOVITIS 185 0.0102
61 IMAGING PROCEDURE ABNORMAL 1 0.0100
62 INFUSION RELATED HYPERSENSITIVITY REACTION 6 0.0100
63 GLOSSODYNIA 220 0.0098
64 RENAL PAPILLARY NECROSIS 2 0.0093
65 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 2 0.0087
66 IRRITABLE BOWEL SYNDROME 186 0.0087
67 GRIP STRENGTH DECREASED 76 0.0086
68 ASTEATOSIS 1 0.0085
69 EXOSTOSIS 77 0.0084
70 NECROTIC LYMPHADENOPATHY 1 0.0083
71 COPPER DEFICIENCY 1 0.0083
72 CALCIUM IONISED DECREASED 2 0.0082
73 LIP DRY 74 0.0081
74 OBSTRUCTIVE NEPHROPATHY 1 0.0081
75 HYPERCHOLESTEROLAEMIA 75 0.0078
76 BURSITIS 94 0.0077
77 GASTROINTESTINAL MUCOSAL EXFOLIATION 1 0.0075
78 WALKING AID USER 49 0.0074
79 HAPTOGLOBIN INCREASED 1 0.0073
80 EAR, NOSE AND THROAT DISORDER 1 0.0071
81 HEPATIC ENZYME 1 0.0067
82 WOUND 187 0.0067
83 LIMB FRACTURE 1 0.0067
84 FOOT DEFORMITY 73 0.0066
85 WOUND INFECTION 71 0.0065
86 IMPAIRED HEALING 203 0.0062
87 ADENOCARCINOMA OF THE CERVIX 1 0.0062
88 ADNEXA UTERI CYST 1 0.0061
89 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
90 DYSAESTHESIA PHARYNX 1 0.0057
91 FLUID IMBALANCE 4 0.0057
92 HERPES ZOSTER MENINGITIS 1 0.0055
93 SYSTEMIC LUPUS ERYTHEMATOSUS 194 0.0055
94 PANCREATIC ENLARGEMENT 2 0.0054
95 ADENOCARCINOMA GASTRIC 5 0.0054
96 JOINT RANGE OF MOTION DECREASED 71 0.0053
97 LUPUS-LIKE SYNDROME 48 0.0053
98 IMMUNE-MEDIATED PANCREATITIS 2 0.0052
99 SEDATION COMPLICATION 13 0.0051
100 CONVULSIVE THRESHOLD LOWERED 2 0.0051
101 NORMOCHROMIC ANAEMIA 1 0.0050
102 LIVE BIRTH 41 0.0049
103 ADENOCARCINOMA METASTATIC 1 0.0049
104 COLONY STIMULATING FACTOR THERAPY 1 0.0048
105 RECTAL FISSURE 3 0.0048
106 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 1 0.0047
107 SCIATICA 73 0.0046
108 CONTRAINDICATED PRODUCT ADMINISTERED 138 0.0046
109 CARCINOID CRISIS 1 0.0044
110 INFUSION RELATED REACTION 291 0.0044
111 SERONEGATIVE ARTHRITIS 5 0.0044
112 PELVIC ABSCESS 5 0.0044
113 HEPATIC CIRRHOSIS 81 0.0043
114 LOWER RESPIRATORY TRACT INFECTION 192 0.0042
115 CANCER FATIGUE 1 0.0042
116 CONGENITAL ANOMALY 32 0.0041
117 IMMUNE-MEDIATED THYROIDITIS 2 0.0040
118 DIARRHOEA INFECTIOUS 3 0.0038
119 ARTHROPATHY 210 0.0038
120 INFUSION SITE THROMBOSIS 1 0.0037
121 OBESITY 59 0.0037
122 INTESTINAL ANASTOMOSIS COMPLICATION 1 0.0037
123 FIBROMYALGIA 89 0.0037
124 GASTROENTERITIS ESCHERICHIA COLI 2 0.0037
125 CRANIOCEREBRAL INJURY 11 0.0036
126 BLISTER 204 0.0036
127 WEIGHT FLUCTUATION 38 0.0036
128 LABILE HYPERTENSION 1 0.0036
129 BLOOD PH INCREASED 2 0.0036
130 DUCTAL ADENOCARCINOMA OF PANCREAS 1 0.0036
131 ATOPY 1 0.0036
132 DUODENOGASTRIC REFLUX 1 0.0036
133 LOWER LIMB FRACTURE 69 0.0036
134 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 3 0.0036
135 DISCOMFORT 214 0.0035
136 PULMONARY FIBROSIS 66 0.0034
137 ILL-DEFINED DISORDER 208 0.0034
138 GALLBLADDER OEDEMA 1 0.0034
139 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 58 0.0034
140 STOMATITIS 207 0.0034
141 DEVICE COMPUTER ISSUE 1 0.0033
142 ENTEROBACTER BACTERAEMIA 1 0.0033
143 DECREASED EYE CONTACT 1 0.0033
144 HEPATECTOMY 1 0.0032
145 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 1 0.0032
146 LIVER INJURY 78 0.0032
147 OESOPHAGEAL FISTULA 1 0.0031
148 ALOPECIA TOTALIS 1 0.0030
149 HEPATIC ENZYME INCREASED 208 0.0030
150 PRESCRIBED OVERDOSE 59 0.0030
151 GASTRIC MUCOSA ERYTHEMA 1 0.0030
152 OCULAR MYASTHENIA 1 0.0029
153 METASTATIC GASTRIC CANCER 1 0.0029
154 NEUTROPENIC COLITIS 6 0.0029
155 CIRCUMORAL OEDEMA 1 0.0029
156 EAR INFECTION 75 0.0028
157 INTESTINAL METASTASIS 1 0.0028
158 DELIRIUM 95 0.0027
159 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 1 0.0027
160 FREQUENT BOWEL MOVEMENTS 73 0.0027
161 ACETABULUM FRACTURE 1 0.0027
162 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
163 OBSTRUCTIVE UROPATHY 1 0.0025
164 INJURY 174 0.0025
165 SPONDYLITIS 9 0.0025
166 IIIRD NERVE PARALYSIS 2 0.0025
167 ENTEROCOCCAL SEPSIS 2 0.0025
168 LARGE INTESTINE INFECTION 3 0.0024
169 GASTROINTESTINAL DISORDER 214 0.0024
170 TYPE 2 DIABETES MELLITUS 80 0.0024
171 OROPHARYNGEAL SPASM 1 0.0024
172 EYE INJURY 7 0.0023
173 HIP ARTHROPLASTY 35 0.0023
174 ANION GAP INCREASED 3 0.0022
175 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2 0.0022
176 ENLARGED UVULA 1 0.0022
177 MENINGOENCEPHALITIS HERPETIC 1 0.0022
178 FIBROADENOMA OF BREAST 1 0.0022
179 MUSCLE MASS 1 0.0022
180 CONTUSION 212 0.0022
181 PREGNANCY 44 0.0022
182 IMMUNE-MEDIATED LUNG DISEASE 4 0.0022
183 EPIDERMOLYSIS 1 0.0022
184 JOINT DISLOCATION 23 0.0022
185 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
186 INFUSION SITE HAEMATOMA 1 0.0021
187 BLEPHAROSPASM 13 0.0021
188 DEVICE RELATED THROMBOSIS 2 0.0020
189 LABORATORY TEST ABNORMAL 59 0.0020
190 RED BLOOD CELL SEDIMENTATION RATE INCREASED 22 0.0020
191 ORBITAL OEDEMA 1 0.0020
192 BREAST ABSCESS 2 0.0020
193 BLOOD CHOLESTEROL INCREASED 91 0.0020
194 CORONAVIRUS TEST POSITIVE 2 0.0019
195 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
196 NIGHT SWEATS 61 0.0019
197 IMMUNE-MEDIATED ENCEPHALITIS 1 0.0019
198 COLITIS ULCERATIVE 84 0.0019
199 PSORIATIC ARTHROPATHY 76 0.0019
200 SLEEP DISORDER 132 0.0019
201 PROTEIN TOTAL DECREASED 7 0.0019
202 GALLBLADDER ENLARGEMENT 2 0.0019
203 IRON OVERLOAD 2 0.0019
204 SWELLING 172 0.0018
205 PRODUCT NAME CONFUSION 2 0.0018
206 SINUSITIS 187 0.0018
207 ROAD TRAFFIC ACCIDENT 75 0.0018
208 OEDEMATOUS PANCREATITIS 1 0.0018
209 MOANING 2 0.0018
210 KNEE ARTHROPLASTY 37 0.0018
211 CARBON DIOXIDE DECREASED 2 0.0017
212 FEELING HOT 106 0.0017
213 INFUSION SITE INFECTION 4 0.0017
214 WHITE BLOOD CELL COUNT INCREASED 66 0.0017
215 BONE MARROW TOXICITY 2 0.0017
216 AGRAPHIA 1 0.0017
217 INFUSION SITE REACTION 5 0.0017
218 GENERAL PHYSICAL HEALTH DETERIORATION 189 0.0016
219 LIVER DISORDER 72 0.0016
220 OTOTOXICITY 3 0.0016
221 HEPATOBILIARY DISEASE 1 0.0016
222 RHEUMATOID ARTHRITIS 180 0.0016
223 METASTASES TO PELVIS 1 0.0016
224 TESTICULAR SWELLING 2 0.0016
225 GLIOMA 1 0.0016
226 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
227 SLOW RESPONSE TO STIMULI 2 0.0015
228 RECTAL HAEMORRHAGE 66 0.0015
229 JOINT SWELLING 183 0.0015
230 LUNG DISORDER 74 0.0015
231 MATERNAL EXPOSURE DURING PREGNANCY 134 0.0015
232 DEFAECATION DISORDER 1 0.0015
233 SPINAL FUSION SURGERY 6 0.0015
234 AORTITIS 1 0.0015
235 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
236 HAIR DISORDER 12 0.0015
237 PUSTULAR PSORIASIS 5 0.0015
238 OSTEOARTHRITIS 61 0.0014
239 DEATH NEONATAL 2 0.0014
240 INFLAMMATION 73 0.0014
241 MUSCULOSKELETAL PAIN 74 0.0014
242 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
243 PSYCHOLOGICAL TRAUMA 12 0.0014
244 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
245 CONFUSIONAL STATE 223 0.0014
246 AMNESIA 89 0.0014
247 CLONIC CONVULSION 1 0.0014
248 DIET REFUSAL 1 0.0014
249 OTITIS MEDIA ACUTE 1 0.0014
250 FIBROCYSTIC BREAST DISEASE 1 0.0014
251 APRAXIA 2 0.0013
252 CHOLANGITIS ACUTE 1 0.0013
253 BREAST CANCER STAGE II 11 0.0013
254 INFECTION 191 0.0013
255 MALIGNANT ASCITES 1 0.0013
256 ALOPECIA 256 0.0013
257 PRESCRIBED UNDERDOSE 26 0.0013
258 HYPERSENSITIVITY 241 0.0013
259 MEAN CELL VOLUME DECREASED 2 0.0013
260 ABDOMINAL DISCOMFORT 213 0.0013
261 OSTEOPOROSIS 51 0.0012
262 FEBRILE NEUTROPENIA 82 0.0012
263 CHEMICAL INJURY 1 0.0012
264 GASTRIC CANCER STAGE III 1 0.0012
265 PERIPHERAL SWELLING 188 0.0012
266 OEDEMA 66 0.0012
267 PERSECUTORY DELUSION 3 0.0012
268 PANCREATITIS 63 0.0012
269 WHEEZING 70 0.0012
270 SEIZURE LIKE PHENOMENA 2 0.0012
271 DRY MOUTH 94 0.0012
272 BLOOD CHLORIDE INCREASED 2 0.0012
273 NAIL DISORDER 10 0.0011
274 RESPIRATORY DEPRESSION 14 0.0011
275 ENTEROCUTANEOUS FISTULA 1 0.0011
276 GASTROINTESTINAL OEDEMA 2 0.0011
277 INCORRECT PRODUCT FORMULATION ADMINISTERED 1 0.0011
278 MADAROSIS 13 0.0011
279 BLOOD SODIUM INCREASED 3 0.0011
280 ARTHRITIS 87 0.0011
281 MOBILITY DECREASED 79 0.0011
282 CLONUS 3 0.0011
283 THERAPEUTIC PRODUCT EFFECT DECREASED 49 0.0011
284 DISORGANISED SPEECH 2 0.0011
285 ENTEROCOLITIS INFECTIOUS 1 0.0011
286 HAEMOCHROMATOSIS 1 0.0011
287 LEUKOENCEPHALOPATHY 4 0.0011
288 ADENOCARCINOMA OF COLON 2 0.0011
289 JOINT STIFFNESS 28 0.0011
290 SMALL INTESTINAL PERFORATION 2 0.0011
291 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
292 PNEUMATOSIS INTESTINALIS 3 0.0011
293 TUMOUR HAEMORRHAGE 3 0.0011
294 ONCOLOGIC COMPLICATION 1 0.0010
295 CROSS SENSITIVITY REACTION 1 0.0010
296 RHINOVIRUS INFECTION 4 0.0010
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 49 0.0010
298 DUODENAL PERFORATION 1 0.0010
299 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
300 STAPHYLOCOCCAL SEPSIS 5 0.0010
301 MUCOSAL DISORDER 1 0.0010
302 BLADDER CANCER RECURRENT 1 0.0010
303 RESPIRATORY DISORDER 30 0.0010
304 THERAPY NON-RESPONDER 45 0.0010
305 GAIT INABILITY 33 0.0010
306 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
307 HYPERURICAEMIA 4 0.0010
308 ALVEOLITIS ALLERGIC 1 0.0010
309 HAIR COLOUR CHANGES 12 0.0010
310 AXILLARY MASS 1 0.0010
311 NASOPHARYNGITIS 177 0.0010
312 ASTHMA 108 0.0010
313 CYTOKINE RELEASE SYNDROME 19 0.0009
314 FLUSHING 95 0.0009
315 BONE NEOPLASM 1 0.0009
316 INFUSION SITE MASS 1 0.0009
317 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
318 DIABETIC NEPHROPATHY 2 0.0009
319 HAIR TEXTURE ABNORMAL 12 0.0009
320 ADENOCARCINOMA 2 0.0009
321 MYOSITIS 8 0.0009
322 ADMINISTRATION SITE PAIN 1 0.0009
323 ENTEROCOLITIS 5 0.0009
324 HYPOVOLAEMIA 5 0.0009
325 WEIGHT INCREASED 191 0.0009
326 THROMBOTIC THROMBOCYTOPENIC PURPURA 3 0.0009
327 ODYNOPHAGIA 5 0.0008
328 DYSPEPSIA 82 0.0008
329 BRONCHIAL HYPERREACTIVITY 1 0.0008
330 PULSE ABNORMAL 2 0.0008
331 RASH VESICULAR 4 0.0008
332 CLOSTRIDIUM COLITIS 1 0.0008
333 FEBRILE CONVULSION 1 0.0008
334 THROMBOCYTOSIS 3 0.0008
335 OTITIS EXTERNA 1 0.0008
336 MUSCULOSKELETAL STIFFNESS 71 0.0008
337 BLOOD UREA DECREASED 1 0.0008
338 ALLERGY TO CHEMICALS 1 0.0008
339 ERYSIPELAS 4 0.0008
340 HYPERAESTHESIA TEETH 1 0.0008
341 LIP DISCOLOURATION 1 0.0008
342 APPLICATION SITE WARMTH 1 0.0008
343 CANCER PAIN 2 0.0008
344 INFUSION SITE IRRITATION 1 0.0008
345 DACRYOSTENOSIS ACQUIRED 1 0.0008
346 BILIARY OBSTRUCTION 1 0.0008
347 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
348 NEUTROPHIL COUNT DECREASED 31 0.0008
349 LARYNGOSPASM 2 0.0007
350 C-REACTIVE PROTEIN INCREASED 27 0.0007
351 VITAMIN B12 DEFICIENCY 3 0.0007
352 ULCER HAEMORRHAGE 5 0.0007
353 SUBDURAL HAEMORRHAGE 2 0.0007
354 EXTRAVASATION 3 0.0007
355 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
356 EXPOSURE DURING PREGNANCY 45 0.0007
357 HEART RATE ABNORMAL 4 0.0007
358 ONYCHOMADESIS 3 0.0007
359 HALLUCINATIONS, MIXED 3 0.0007
360 CULTURE URINE POSITIVE 1 0.0007
361 CHEST PAIN 131 0.0007
362 INTENSIVE CARE 1 0.0007
363 BLOOD ELECTROLYTES DECREASED 1 0.0007
364 NAIL INFECTION 1 0.0007
365 NOROVIRUS INFECTION 1 0.0007
366 MIGRAINE 66 0.0007
367 MUTISM 1 0.0007
368 TREATMENT FAILURE 57 0.0007
369 INSOMNIA 183 0.0007
370 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
371 PARONYCHIA 3 0.0007
372 MUSCULAR WEAKNESS 77 0.0007
373 INFUSION SITE INDURATION 1 0.0007
374 GASTRITIS HAEMORRHAGIC 1 0.0007
375 PYREXIA 231 0.0007
376 PANCREATITIS ACUTE 15 0.0007
377 HYPERTHERMIA 5 0.0007
378 CONDITION AGGRAVATED 199 0.0007
379 BLOOD PRESSURE IMMEASURABLE 1 0.0007
380 OESOPHAGITIS 7 0.0006
381 BLOOD CREATININE DECREASED 2 0.0006
382 SKIN TIGHTNESS 3 0.0006
383 ABDOMINAL PAIN 148 0.0006
384 FUNGAEMIA 1 0.0006
385 THROAT TIGHTNESS 17 0.0006
386 PNEUMONITIS 17 0.0006
387 HYPOAESTHESIA 93 0.0006
388 COLON CANCER METASTATIC 1 0.0006
389 LIVER ABSCESS 2 0.0006
390 HEPATIC NEOPLASM 2 0.0006
391 HYPOGAMMAGLOBULINAEMIA 4 0.0006
392 INJECTION SITE INFECTION 2 0.0006
393 HOSPICE CARE 6 0.0006
394 HYPERVOLAEMIA 3 0.0006
395 ARTHROPOD STING 1 0.0006
396 FLUID INTAKE REDUCED 3 0.0006
397 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
398 BACTERAEMIA 7 0.0006
399 FOOD AVERSION 1 0.0006
400 PHLEBITIS 3 0.0006
401 FEMALE GENITAL TRACT FISTULA 1 0.0006
402 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
403 WOUND COMPLICATION 2 0.0006
404 OEDEMA PERIPHERAL 71 0.0006
405 DYSPNOEA 329 0.0006
406 UNDERDOSE 42 0.0006
407 HYPOPITUITARISM 1 0.0006
408 HYPOMAGNESAEMIA 8 0.0006
409 THROMBOPHLEBITIS 2 0.0006
410 ALOPECIA AREATA 1 0.0006
411 DRUG INTOLERANCE 55 0.0006
412 SERUM FERRITIN INCREASED 3 0.0006
413 SMALL INTESTINAL OBSTRUCTION 7 0.0006
414 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
415 PULMONARY TOXICITY 4 0.0006
416 LEUKOPENIA 28 0.0006
417 PRURITUS 214 0.0006
418 ANAL ABSCESS 3 0.0006
419 OROPHARYNGEAL DISCOMFORT 5 0.0006
420 NORMAL NEWBORN 3 0.0006
421 CEREBRAL VENOUS THROMBOSIS 1 0.0006
422 ARTHRALGIA 229 0.0006
423 BLOOD PHOSPHORUS DECREASED 2 0.0005
424 CHEST DISCOMFORT 56 0.0005
425 ESSENTIAL HYPERTENSION 1 0.0005
426 ASCITES 16 0.0005
427 HYPOMANIA 2 0.0005
428 ANAPHYLACTIC REACTION 30 0.0005
429 UNRESPONSIVE TO STIMULI 14 0.0005
430 HYPOXIA 19 0.0005
431 GRANULOCYTE COUNT DECREASED 1 0.0005
432 MEMORY IMPAIRMENT 74 0.0005
433 MALNUTRITION 6 0.0005
434 ORAL CANDIDIASIS 7 0.0005
435 CHEMOTHERAPY 2 0.0005
436 HYPERTENSION 112 0.0005
437 THROMBOCYTOPENIA 59 0.0005
438 MYELOPATHY 1 0.0005
439 NEUROLOGICAL SYMPTOM 3 0.0005
440 HYPOREFLEXIA 1 0.0005
441 HEPATIC MASS 1 0.0005
442 RETCHING 11 0.0005
443 HYPOALBUMINAEMIA 4 0.0005
444 NEUROTOXICITY 9 0.0005
445 BICYTOPENIA 1 0.0005
446 ABDOMINAL PAIN UPPER 105 0.0005
447 VISUAL IMPAIRMENT 63 0.0005
448 BLOOD ALBUMIN DECREASED 4 0.0005
449 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
450 NEUTROPENIA 68 0.0005
451 CYSTITIS HAEMORRHAGIC 2 0.0005
452 DECREASED APPETITE 115 0.0005
453 DERMATITIS ACNEIFORM 3 0.0005
454 MUSCLE CONTRACTURE 1 0.0005
455 MUSCLE SPASTICITY 6 0.0005
456 DIVERTICULAR PERFORATION 1 0.0005
457 MEDICATION ERROR 27 0.0005
458 URTICARIA 81 0.0005
459 PARAESTHESIA 76 0.0005
460 DRUG-INDUCED LIVER INJURY 15 0.0005
461 PERICARDIAL EFFUSION 11 0.0005
462 SCREAMING 3 0.0005
463 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
464 GASTRIC CANCER STAGE IV 1 0.0005
465 MUCOSAL INFLAMMATION 12 0.0005
466 ANXIETY 130 0.0005
467 DISABILITY 9 0.0005
468 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
469 RASH 197 0.0005
470 MUSCLE SPASMS 82 0.0004
471 HAEMOLYTIC ANAEMIA 4 0.0004
472 BLOOD CALCIUM DECREASED 5 0.0004
473 TASTE DISORDER 9 0.0004
474 GASTRIC POLYPS 1 0.0004
475 SUSPECTED OFF LABEL USE 2 0.0004
476 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
477 TACHYCARDIA 39 0.0004
478 HYPERTRANSAMINASAEMIA 3 0.0004
479 DISCOURAGEMENT 1 0.0004
480 EPILEPSY 13 0.0004
481 GAIT DISTURBANCE 81 0.0004
482 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
483 PULSE ABSENT 2 0.0004
484 GASTROINTESTINAL TOXICITY 2 0.0004
485 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
486 SINUS BRADYCARDIA 4 0.0004
487 LYMPHADENITIS 1 0.0004
488 EAR PAIN 8 0.0004
489 CYTOPENIA 5 0.0004
490 ENCEPHALOPATHY 10 0.0004
491 GENERAL SYMPTOM 3 0.0004
492 NEUROPATHY PERIPHERAL 38 0.0004
493 COLITIS 15 0.0004
494 CHEMICAL BURN OF SKIN 1 0.0004
495 TROPONIN INCREASED 3 0.0004
496 AMMONIA INCREASED 2 0.0004
497 ILEOSTOMY 1 0.0004
498 OXYGEN SATURATION DECREASED 22 0.0004
499 DEPRESSION 89 0.0004
500 INCREASED BRONCHIAL SECRETION 1 0.0004
501 HYPOKALAEMIA 18 0.0004
502 CACHEXIA 2 0.0004
503 HYPERBILIRUBINAEMIA 4 0.0004
504 CATHETER SITE PAIN 1 0.0004
505 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
506 NYSTAGMUS 2 0.0004
507 ABDOMINAL MASS 1 0.0004
508 COMPRESSION FRACTURE 2 0.0004
509 LIVER FUNCTION TEST INCREASED 8 0.0004
510 DECREASED ACTIVITY 4 0.0004
511 ABDOMINAL RIGIDITY 1 0.0004
512 MIGRAINE WITH AURA 1 0.0004
513 GASTRIC PERFORATION 1 0.0004
514 HICCUPS 3 0.0004
515 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
516 EMBOLISM 3 0.0004
517 MACULE 1 0.0004
518 ANGIOPATHY 2 0.0004
519 HYPERGLYCAEMIA 13 0.0004
520 ENDOTRACHEAL INTUBATION 1 0.0004
521 NEUTROPHIL COUNT ABNORMAL 1 0.0004
522 OESOPHAGEAL STENOSIS 1 0.0004
523 DUODENAL ULCER HAEMORRHAGE 1 0.0003
524 LIP PAIN 1 0.0003
525 BLOOD MAGNESIUM DECREASED 3 0.0003
526 ELECTROLYTE IMBALANCE 4 0.0003
527 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
528 HYPONATRAEMIA 19 0.0003
529 CHOLECYSTITIS 4 0.0003
530 PAIN 206 0.0003
531 ATYPICAL PNEUMONIA 1 0.0003
532 BLOOD CULTURE POSITIVE 1 0.0003
533 ASTHENIA 124 0.0003
534 VOMITING 155 0.0003
535 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
536 MASTICATION DISORDER 1 0.0003
537 DYSAESTHESIA 1 0.0003
538 DUODENITIS 1 0.0003
539 ADVERSE EVENT 30 0.0003
540 THERAPY PARTIAL RESPONDER 5 0.0003
541 FLANK PAIN 3 0.0003
542 FATIGUE 248 0.0003
543 CYANOSIS 5 0.0003
544 INFUSION SITE SWELLING 2 0.0003
545 DRUG EFFECT INCREASED 1 0.0003
546 BLADDER PAIN 1 0.0003
547 HEPATOTOXICITY 7 0.0003
548 ORTHOPNOEA 1 0.0003
549 ENTERITIS 2 0.0003
550 CUSHINGOID 1 0.0003
551 ANAEMIA 59 0.0003
552 RESPIRATORY TRACT INFECTION 8 0.0003
553 BACTERIAL SEPSIS 1 0.0003
554 PHARYNGEAL SWELLING 3 0.0003
555 PRODUCT PREPARATION ISSUE 2 0.0003
556 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
557 NEPHRITIS 1 0.0003
558 BLOOD UREA INCREASED 5 0.0003
559 PRODUCT USE ISSUE 56 0.0003
560 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
561 PNEUMONIA 96 0.0003
562 NEOPLASM RECURRENCE 1 0.0003
563 HEPATIC CYST 1 0.0003
564 WEIGHT DECREASED 82 0.0003
565 EYE MOVEMENT DISORDER 2 0.0003
566 HAEMATURIA 10 0.0003
567 DIABETIC KETOACIDOSIS 7 0.0003
568 SYNCOPE 29 0.0003
569 DROOLING 2 0.0003
570 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
571 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
572 EMBOLIC STROKE 1 0.0003
573 DEPRESSIVE SYMPTOM 1 0.0003
574 HYPOTHYROIDISM 9 0.0003
575 SINUS TACHYCARDIA 4 0.0003
576 FIBRIN D DIMER INCREASED 1 0.0003
577 METASTASIS 2 0.0003
578 NEUTROPENIC SEPSIS 2 0.0003
579 IMPAIRED QUALITY OF LIFE 4 0.0003
580 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
581 PARAESTHESIA ORAL 4 0.0003
582 TONGUE DISORDER 2 0.0003
583 BACK INJURY 3 0.0003
584 MONOCYTE COUNT INCREASED 1 0.0003
585 PELVIC PAIN 5 0.0003
586 PLATELET COUNT DECREASED 29 0.0003
587 DIZZINESS 135 0.0003
588 NAUSEA 213 0.0003
589 PANCYTOPENIA 15 0.0003
590 BACTERIAL INFECTION 5 0.0003
591 BACK PAIN 62 0.0003
592 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
593 MITRAL VALVE INCOMPETENCE 3 0.0003
594 MYOCARDIAL ISCHAEMIA 3 0.0003
595 RESPIRATORY FAILURE 19 0.0003
596 OESOPHAGEAL ULCER 1 0.0003
597 ACUTE RESPIRATORY FAILURE 5 0.0003
598 BLOOD BILIRUBIN INCREASED 7 0.0003
599 FAECES HARD 1 0.0003
600 APNOEA 2 0.0003
601 CARDIOPULMONARY FAILURE 1 0.0003
602 SPLENOMEGALY 3 0.0003
603 TREATMENT NONCOMPLIANCE 14 0.0003
604 HAEMATOCRIT DECREASED 5 0.0003
605 DIARRHOEA 162 0.0003
606 OESOPHAGEAL CANDIDIASIS 1 0.0003
607 ATRIAL FLUTTER 2 0.0003
608 PRESYNCOPE 6 0.0002
609 BACK DISORDER 4 0.0002
610 BODY TEMPERATURE INCREASED 5 0.0002
611 ANAPHYLACTOID REACTION 1 0.0002
612 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
613 ABDOMINAL PAIN LOWER 6 0.0002
614 INFUSION SITE ERYTHEMA 2 0.0002
615 HYPERPYREXIA 1 0.0002
616 ABSCESS LIMB 1 0.0002
617 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
618 VITAMIN D DECREASED 2 0.0002
619 INFUSION SITE PAIN 3 0.0002
620 ANAPHYLACTIC SHOCK 6 0.0002
621 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
622 BONE CANCER 1 0.0002
623 SEPTIC SHOCK 10 0.0002
624 ERYTHEMA 47 0.0002
625 HYPOGLYCAEMIA 11 0.0002
626 LYMPHADENOPATHY 8 0.0002
627 TRANSAMINASES INCREASED 5 0.0002
628 TACHYPNOEA 3 0.0002
629 DRUG EFFECT DELAYED 1 0.0002
630 PALLOR 6 0.0002
631 IMPAIRED GASTRIC EMPTYING 3 0.0002
632 HAEMOGLOBIN INCREASED 1 0.0002
633 RESPIRATORY DISTRESS 6 0.0002
634 HYPERHIDROSIS 28 0.0002
635 UROSEPSIS 2 0.0002
636 IRON DEFICIENCY ANAEMIA 2 0.0002
637 MALAISE 95 0.0002
638 LOCALISED OEDEMA 1 0.0002
639 NEPHROGENIC ANAEMIA 1 0.0002
640 BLOOD CREATININE INCREASED 14 0.0002
641 PLEURAL EFFUSION 13 0.0002
642 DEVICE OCCLUSION 3 0.0002
643 LEUKAEMIA 2 0.0002
644 HYPOCALCAEMIA 4 0.0002
645 HAEMATOTOXICITY 2 0.0002
646 BRONCHOSPASM 3 0.0002
647 HYPOVOLAEMIC SHOCK 1 0.0002
648 NON-SMALL CELL LUNG CANCER 1 0.0002
649 BLOOD PRESSURE FLUCTUATION 5 0.0002
650 ATELECTASIS 2 0.0002
651 ENTEROCOCCAL INFECTION 1 0.0002
652 INFLAMMATORY BOWEL DISEASE 2 0.0002
653 COELIAC DISEASE 2 0.0002
654 HEPATOMEGALY 2 0.0002
655 VITREOUS FLOATERS 2 0.0002
656 ORGANISING PNEUMONIA 1 0.0002
657 PULMONARY MASS 3 0.0002
658 ABDOMINAL TENDERNESS 1 0.0002
659 NEOPLASM PROGRESSION 7 0.0002
660 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
661 ADVERSE DRUG REACTION 18 0.0002
662 HAEMATEMESIS 5 0.0002
663 FEEDING DISORDER 4 0.0002
664 DYSLIPIDAEMIA 1 0.0002
665 EYELID PTOSIS 2 0.0002
666 HYPOPHAGIA 5 0.0002
667 TEMPERATURE INTOLERANCE 2 0.0002
668 FAILURE TO THRIVE 1 0.0002
669 BRAIN FOG 3 0.0002
670 BLOOD LACTIC ACID INCREASED 1 0.0002
671 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
672 HEADACHE 118 0.0002
673 SENSORY DISTURBANCE 3 0.0002
674 BREAST CANCER METASTATIC 2 0.0002
675 DYSARTHRIA 7 0.0002
676 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
677 HYDROCEPHALUS 1 0.0002
678 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
679 MANIA 3 0.0002
680 CHOKING SENSATION 1 0.0002
681 MENTAL STATUS CHANGES 5 0.0002
682 RASH MACULO-PAPULAR 4 0.0002
683 THROAT IRRITATION 8 0.0002
684 NEPHROPATHY TOXIC 2 0.0002
685 CANDIDA INFECTION 3 0.0002
686 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
687 GENERALISED ERYTHEMA 1 0.0002
688 NEUTROPHILIA 1 0.0002
689 HYPERTONIA 1 0.0002
690 PARANOIA 3 0.0002
691 BLOOD URIC ACID INCREASED 1 0.0002
692 METASTASES TO LUNG 2 0.0002
693 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
694 HYPERTRIGLYCERIDAEMIA 1 0.0002
695 CARDIAC ARREST 14 0.0002
696 COVID-19 PNEUMONIA 2 0.0002
697 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
698 CARDIO-RESPIRATORY ARREST 7 0.0002
699 PRODUCT USE IN UNAPPROVED INDICATION 41 0.0002
700 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
701 LARYNGEAL OEDEMA 1 0.0002
702 OFF LABEL USE 142 0.0002
703 ILEUS 2 0.0002
704 INFUSION SITE EXTRAVASATION 1 0.0002
705 NASAL DRYNESS 1 0.0002
706 MUSCLE ATROPHY 2 0.0002
707 PROTEINURIA 3 0.0002
708 FOREIGN BODY SENSATION IN EYES 1 0.0002
709 MYDRIASIS 2 0.0002
710 INCOHERENT 1 0.0002
711 HERPES SIMPLEX 1 0.0002
712 SEDATION 4 0.0002
713 DISEASE PROGRESSION 18 0.0002
714 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
715 ACUTE KIDNEY INJURY 23 0.0002
716 HYPOTENSION 30 0.0001
717 CHOLECYSTITIS CHRONIC 1 0.0001
718 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
719 FULL BLOOD COUNT DECREASED 3 0.0001
720 RASH PRURITIC 8 0.0001
721 UVEITIS 2 0.0001
722 ABNORMAL LOSS OF WEIGHT 1 0.0001
723 AKATHISIA 2 0.0001
724 DRUG INTERACTION 23 0.0001
725 INTERSTITIAL LUNG DISEASE 7 0.0001
726 DIVERTICULITIS 4 0.0001
727 LARGE INTESTINE PERFORATION 1 0.0001
728 FORMICATION 1 0.0001
729 HOSPITALISATION 22 0.0001
730 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
731 DUODENAL ULCER 1 0.0001
732 LYMPHOPENIA 2 0.0001
733 HAND FRACTURE 1 0.0001
734 MYELOSUPPRESSION 5 0.0001
735 SEIZURE 16 0.0001
736 HYPERTHYROIDISM 2 0.0001
737 HYPOKINESIA 2 0.0001
738 FLUID RETENTION 7 0.0001
739 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
740 GASTROENTERITIS 2 0.0001
741 PULMONARY EMBOLISM 13 0.0001
742 THERAPY CESSATION 7 0.0001
743 HYPOPHOSPHATAEMIA 1 0.0001
744 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
745 MEDICAL DEVICE COMPLICATION 1 0.0001
746 URINARY INCONTINENCE 4 0.0001
747 IMMUNODEFICIENCY 2 0.0001
748 BLOOD POTASSIUM DECREASED 4 0.0001
749 CHROMATURIA 3 0.0001
750 HYPOAESTHESIA ORAL 2 0.0001
751 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
752 TINNITUS 6 0.0001
753 LIPASE INCREASED 1 0.0001
754 DEVICE RELATED INFECTION 2 0.0001
755 APHTHOUS ULCER 1 0.0001
756 HAEMORRHAGIC STROKE 1 0.0001
757 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
758 HAEMATOCHEZIA 7 0.0001
759 FURUNCLE 1 0.0001
760 GINGIVAL PAIN 1 0.0001
761 PREMATURE DELIVERY 2 0.0001
762 ABSCESS 2 0.0001
763 MYASTHENIA GRAVIS 1 0.0001
764 PAIN IN EXTREMITY 36 0.0001
765 ABNORMAL FAECES 1 0.0001
766 BRONCHITIS 9 0.0001
767 BLOOD PRESSURE DECREASED 8 0.0001
768 PNEUMONIA ASPIRATION 3 0.0001
769 COAGULOPATHY 2 0.0001
770 HEMIPARESIS 2 0.0001
771 RASH GENERALISED 3 0.0001
772 MYOPATHY 1 0.0001
773 DEAFNESS 3 0.0001
774 LOCAL SWELLING 2 0.0001
775 CONSTIPATION 25 0.0001
776 GROIN PAIN 1 0.0001
777 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
778 LYMPHOCYTE COUNT DECREASED 2 0.0001
779 BRADYCARDIA 6 0.0001
780 DEHYDRATION 15 0.0001
781 FACIAL PAIN 1 0.0001
782 JAUNDICE 3 0.0001
783 ANAL INCONTINENCE 1 0.0001
784 CHILLS 13 0.0001
785 COUGH 31 0.0001
786 OPTIC NEURITIS 1 0.0001
787 RESPIRATORY ARREST 3 0.0001
788 OVARIAN CANCER 1 0.0001
789 DEEP VEIN THROMBOSIS 7 0.0001
790 SEPSIS 12 0.0001
791 SWELLING FACE 7 0.0001
792 RENAL DISORDER 5 0.0001
793 NEPHROPATHY 1 0.0001
794 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
795 RED BLOOD CELL COUNT DECREASED 3 0.0001
796 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
797 PLASMA CELL MYELOMA 4 0.0001
798 BLOOD PRESSURE ABNORMAL 2 0.0001
799 BRAIN INJURY 1 0.0001
800 HEPATIC FAILURE 3 0.0001
801 EMOTIONAL DISTRESS 12 0.0001
802 PRODUCT ADMINISTRATION ERROR 2 0.0001
803 DRY THROAT 1 0.0001
804 MOTOR DYSFUNCTION 1 0.0001
805 PRODUCT PREPARATION ERROR 2 0.0001
806 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
807 LOSS OF CONSCIOUSNESS 12 0.0001
808 STAPHYLOCOCCAL INFECTION 3 0.0001
809 GASTROINTESTINAL PAIN 1 0.0001
810 MELAENA 2 0.0001
811 DEATH 78 0.0001
812 LIP SWELLING 3 0.0001
813 TOOTH DISORDER 2 0.0001
814 INTESTINAL PERFORATION 1 0.0001
815 FISTULA 1 0.0001
816 EYE INFECTION 1 0.0001
817 HAEMOGLOBIN DECREASED 9 0.0001
818 NEOPLASM 1 0.0001
819 ABDOMINAL DISTENSION 9 0.0001
820 NASAL CONGESTION 5 0.0001
821 ARRHYTHMIA 4 0.0001
822 PRODUCT PRESCRIBING ERROR 2 0.0001
823 THERAPY INTERRUPTED 6 0.0001
824 HYPERLIPIDAEMIA 1 0.0001
825 MUSCLE RIGIDITY 1 0.0001
826 HEPATITIS C 1 0.0001
827 THERAPEUTIC RESPONSE DECREASED 5 0.0001
828 ADRENAL INSUFFICIENCY 1 0.0001
829 AGITATION 6 0.0001
830 HYPERCALCAEMIA 1 0.0001
831 DYSGEUSIA 6 0.0001
832 HEART RATE INCREASED 8 0.0001
833 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
834 HEPATIC FUNCTION ABNORMAL 3 0.0001
835 INJECTION SITE DISCOLOURATION 1 0.0001
836 BRAIN OEDEMA 1 0.0001
837 GENITAL HAEMORRHAGE 1 0.0001
838 TOXICITY TO VARIOUS AGENTS 13 0.0001
839 NODULE 1 0.0001
840 SPEECH DISORDER 4 0.0001
841 GASTRITIS 2 0.0001
842 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
843 PRODUCT QUALITY ISSUE 10 0.0001
844 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
845 ATRIAL FIBRILLATION 7 0.0001
846 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
847 NECK PAIN 4 0.0001
848 BLOOD TEST ABNORMAL 1 0.0001
849 URINARY TRACT INFECTION 12 0.0001
850 INTENTIONAL DOSE OMISSION 2 0.0001
851 SOMNOLENCE 14 0.0001
852 MYELODYSPLASTIC SYNDROME 1 0.0001
853 FLUID OVERLOAD 1 0.0001
854 INTENTIONAL PRODUCT MISUSE 6 0.0001
855 COVID-19 12 0.0001
856 PALPITATIONS 8 0.0001
857 ACUTE MYOCARDIAL INFARCTION 2 0.0001
858 ANGIOEDEMA 3 0.0001
859 OESOPHAGEAL CARCINOMA 2 0.0001
860 COLON CANCER 1 0.0001
861 DEVICE ADHESION ISSUE 1 0.0001
862 DELUSION 1 0.0001
863 LUNG INFECTION 1 0.0001
864 CARDIAC FAILURE CONGESTIVE 5 0.0001
865 MUSCLE TIGHTNESS 1 0.0001
866 METASTASES TO BONE 1 0.0001
867 OSTEONECROSIS 2 0.0001
868 DRUG LEVEL INCREASED 1 0.0001
869 SKIN DISORDER 2 0.0001
870 URINARY RETENTION 2 0.0001
871 BLOOD PRESSURE INCREASED 9 0.0001
872 CIRCULATORY COLLAPSE 1 0.0001
873 FEELING ABNORMAL 14 0.0001
874 GASTRIC DISORDER 2 0.0001
875 MUSCULOSKELETAL DISCOMFORT 1 0.0001
876 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
877 BURNING SENSATION 4 0.0001
878 HEART RATE DECREASED 2 0.0001
879 METASTASES TO LIVER 1 0.0001
880 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
881 DRUG ERUPTION 1 0.0001
882 CEREBRAL HAEMORRHAGE 2 0.0001
883 DRUG INEFFECTIVE 73 0.0001
884 RESTLESSNESS 2 0.0001
885 OROPHARYNGEAL PAIN 5 0.0001
886 CONJUNCTIVITIS 1 0.0001
887 HEPATIC STEATOSIS 1 0.0001
888 PSORIASIS 7 0.0001
889 DYSPNOEA EXERTIONAL 2 0.0001
890 INTESTINAL OBSTRUCTION 2 0.0001
891 BLOOD SODIUM DECREASED 1 0.0001
892 MYALGIA 9 0.0001
893 FOOT FRACTURE 1 0.0001
894 DYSPHAGIA 5 0.0001
895 GASTRIC ULCER 1 0.0001
896 INCREASED APPETITE 1 0.0001
897 PRODUCT SUBSTITUTION ISSUE 3 0.0001
898 ERUCTATION 1 0.0001
899 DYSPHONIA 3 0.0001
900 HAEMORRHOIDS 1 0.0001
901 ORAL HERPES 1 0.0001
902 BONE PAIN 3 0.0001
903 CARDIAC FAILURE 4 0.0000
904 THROMBOSIS 4 0.0000
905 VERTIGO 3 0.0000
906 BONE MARROW FAILURE 1 0.0000
907 EATING DISORDER 1 0.0000
908 IMPAIRED WORK ABILITY 1 0.0000
909 HYPOACUSIS 2 0.0000
910 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
911 APPLICATION SITE PAIN 1 0.0000
912 SKIN DISCOLOURATION 2 0.0000
913 DEVICE MALFUNCTION 3 0.0000
914 TREMOR 7 0.0000
915 DISEASE RECURRENCE 2 0.0000
916 RASH ERYTHEMATOUS 2 0.0000
917 CEREBROVASCULAR ACCIDENT 7 0.0000
918 MENTAL IMPAIRMENT 1 0.0000
919 NEURALGIA 1 0.0000
920 CEREBRAL INFARCTION 1 0.0000
921 EXTRAPYRAMIDAL DISORDER 1 0.0000
922 EPISTAXIS 3 0.0000
923 AGEUSIA 1 0.0000
924 DRY EYE 2 0.0000
925 HOT FLUSH 3 0.0000
926 CELLULITIS 2 0.0000
927 HEPATITIS 1 0.0000
928 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
929 NO ADVERSE EVENT 7 0.0000
930 HAEMATOMA 1 0.0000
931 DIPLOPIA 1 0.0000
932 DEPRESSED MOOD 2 0.0000
933 INJECTION SITE BRUISING 3 0.0000
934 FEAR 1 0.0000
935 FEELING COLD 1 0.0000
936 CONVULSION 2 0.0000
937 HYPERSOMNIA 1 0.0000
938 HERPES ZOSTER 2 0.0000
939 LIVER FUNCTION TEST ABNORMAL 1 0.0000
940 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
941 APHASIA 1 0.0000
942 LACRIMATION INCREASED 1 0.0000
943 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
944 LIMB DISCOMFORT 1 0.0000
945 NERVOUS SYSTEM DISORDER 1 0.0000
946 BLOOD GLUCOSE INCREASED 6 0.0000
947 RHINORRHOEA 2 0.0000
948 CHOLELITHIASIS 1 0.0000
949 VISION BLURRED 4 0.0000
950 ILLNESS 3 0.0000
951 NIGHTMARE 1 0.0000
952 DEVICE USE ERROR 1 0.0000
953 HYPERKALAEMIA 1 0.0000
954 DRUG EFFECT INCOMPLETE 1 0.0000
955 ACCIDENTAL OVERDOSE 1 0.0000
956 DYSURIA 1 0.0000
957 FALL 9 0.0000
958 INFLUENZA 3 0.0000
959 EYE SWELLING 1 0.0000
960 HALLUCINATION 2 0.0000
961 ACNE 2 0.0000
962 BLINDNESS 1 0.0000
963 OVERDOSE 5 0.0000
964 BALANCE DISORDER 2 0.0000
965 MENTAL DISORDER 1 0.0000
966 MYOCARDIAL INFARCTION 4 0.0000
967 RENAL FAILURE 3 0.0000
968 DRY SKIN 3 0.0000
969 BREAST CANCER 2 0.0000
970 COGNITIVE DISORDER 1 0.0000
971 OCULAR HYPERAEMIA 1 0.0000
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
973 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
974 NERVOUSNESS 1 0.0000
975 HAEMORRHAGE 2 0.0000
976 DISTURBANCE IN ATTENTION 1 0.0000
977 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
978 EYE PAIN 1 0.0000
979 FLATULENCE 1 0.0000
980 LETHARGY 1 0.0000
981 EYE IRRITATION 1 0.0000
982 CATARACT 1 0.0000
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
984 CHRONIC KIDNEY DISEASE 1 0.0000
985 DIABETES MELLITUS 1 0.0000
986 DEVICE ISSUE 1 0.0000
987 CARDIAC DISORDER 1 0.0000
988 PRODUCT DOSE OMISSION ISSUE 3 0.0000
989 INCORRECT DOSE ADMINISTERED 2 0.0000
990 INJECTION SITE ERYTHEMA 1 0.0000